Business Standard

SC clears Monsanto's patent for Bt cotton seed, but biotech firms want more

Biotechnology companies had put on hold new patents and technologies in the agricultural sector in the two years since the controversy began

Bt cotton
Premium

Bt cotton

Rajesh Bhayani Mumbai
While the Supreme Court validated Monsanto’s patent for genetically modified (Bt) cotton seed, in a landmark judgment on Tuesday, leading biotech companies say the way is still not clear for them to introduce new technologies.

For one, the case is not fully over for Monsanto. A spokesperson of Bayer, which now owns Monsanto, notes: “The Supreme Court (SC) restored the order of the single-judge bench of the Delhi high court which, prima facie, validates our patent (but) has sent it back for full trial by evidence, considering the complexities involved. We feel confident about defending any challenge to our patent by

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in